Amalgamated Bank raised its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 27.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,764 shares of the medical device company’s stock after purchasing an additional 2,073 shares during the quarter. Amalgamated Bank’s holdings in Cooper Companies, Inc. (The) were worth $2,338,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Archford Capital Strategies LLC raised its stake in shares of Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock worth $135,000 after purchasing an additional 363 shares during the last quarter. Penserra Capital Management LLC raised its stake in shares of Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock worth $156,000 after purchasing an additional 68 shares during the last quarter. Pacer Advisors Inc. raised its stake in shares of Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after purchasing an additional 31 shares during the last quarter. Visionary Asset Management Inc. purchased a new stake in shares of Cooper Companies, Inc. (The) in the second quarter worth approximately $201,000. Finally, Dai Ichi Life Insurance Company Ltd purchased a new stake in shares of Cooper Companies, Inc. (The) in the first quarter worth approximately $206,000. 95.79% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Amalgamated Bank Has $2.34 Million Stake in Cooper Companies, Inc. (The) (COO)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/18/amalgamated-bank-has-2-34-million-stake-in-cooper-companies-inc-the-coo.html.

In related news, VP Randal Golden sold 1,621 shares of the company’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $243.65, for a total value of $394,956.65. Following the transaction, the vice president now directly owns 1,731 shares of the company’s stock, valued at approximately $421,758.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Daniel G. Mcbride sold 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 21st. The shares were sold at an average price of $244.23, for a total value of $1,465,380.00. Following the completion of the transaction, the chief operating officer now directly owns 34,395 shares in the company, valued at $8,400,290.85. The disclosure for this sale can be found here. Insiders sold a total of 20,992 shares of company stock worth $5,167,628 over the last ninety days. 1.60% of the stock is currently owned by insiders.

Shares of Cooper Companies, Inc. (NYSE:COO) opened at 245.21 on Monday. Cooper Companies, Inc. has a 52-week low of $158.73 and a 52-week high of $256.39. The stock has a market capitalization of $11.98 billion, a P/E ratio of 36.76 and a beta of 0.59. The firm has a 50-day moving average price of $245.23 and a 200-day moving average price of $224.59.

Cooper Companies, Inc. (The) (NYSE:COO) last released its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.30 EPS. On average, analysts predict that Cooper Companies, Inc. will post $9.72 EPS for the current year.

A number of brokerages recently commented on COO. Robert W. Baird reaffirmed a “buy” rating and set a $273.00 price target (up from $267.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Zacks Investment Research raised Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 price target for the company in a research report on Tuesday, August 29th. J P Morgan Chase & Co reaffirmed a “neutral” rating and set a $206.00 price target (up from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Jefferies Group LLC set a $250.00 price target on Cooper Companies, Inc. (The) and gave the company a “buy” rating in a research report on Thursday, August 17th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “hold” rating and set a $250.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Cooper Companies, Inc. (The) currently has a consensus rating of “Buy” and a consensus price target of $257.60.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.